Norwegian study tests new school strategy to boost teen health smarts

NCT ID NCT07601815

Not yet recruiting Knowledge-focused Sponsor: Norwegian Institute of Public Health Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a program called MEST can improve health literacy and mental well-being in high school students aged 16-24. About 1,800 students in Norway will be split into two groups: one using the MEST strategy and one receiving usual school health services. The program adapts to student needs based on a survey, offering classroom sessions, seminars, or individual support. Researchers will measure changes in health literacy and mental health over one school year.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: MEST work strategy (a school-based, adaptive health literacy intervention delivered by school health services)
What this could lead to: If it works, this could point toward a simple, scalable way for schools to boost teens' health literacy and mental well-being.
What could go wrong: This is an early-stage trial with no results yet. The intervention is complex and adaptive, so effects may vary across schools and students.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADOLESCENT HEALTH are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADOLESCENT HEALTH HEALTH LITERACY

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Norwegian Institute of Public Health (NIPH)

Levanger, Trøndelag, 7600, Norway

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.